Is it time for a precision health approach to the management of newborn hyperbilirubinemia?

被引:0
|
作者
Stevenson, David K. [1 ]
Wells, Grant S. [2 ]
Wong, Ronald J. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Stanford, CA 94305 USA
[2] Stanford Univ, Stanford Maternal & Child Hlth Res Inst, Sch Med, Stanford, CA USA
关键词
ZINC-PROTOPORPHYRIN; BILIRUBIN PRODUCTION; SEVERE JAUNDICE; TERM NEWBORNS; HEMOLYSIS; HEME; INHIBITOR; PREDICTION; INFANTS; RISK;
D O I
10.1038/s41372-024-01941-3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Newborn hyperbilirubinemia during the first two weeks of life is one of most common problems requiring management decisions by a pediatrician. However, high bilirubin levels in the circulation have been associated with neurologic injury under a variety of conditions encountered in the newborn infant, such as hemolysis. The risk for developing dangerous hyperbilirubinemia is multifactorial and is determined by a complex set of factors related to a newborn infant's genetic capacities as well as intra- and extrauterine exposures. To this end, a precision health approach based on the integration of prenatal genetic and postnatal diagnostic measures might improve the management of neonatal hyperbilirubinemia.
引用
收藏
页码:920 / 923
页数:4
相关论文
共 50 条
  • [1] Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia
    Bhutani, Vinod K.
    Srinivas, Shanmukha
    Cuadrado, Martin E. Castillo
    Aby, Janelle L.
    Wong, Ronald J.
    Stevenson, David K.
    ACTA PAEDIATRICA, 2016, 105 (05) : E189 - E194
  • [2] Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease
    Rosenfeld, Warren N.
    Hudak, Mark L.
    Ruiz, Nancy
    Gautam, Shiva
    JOURNAL OF PERINATOLOGY, 2022, 42 (01) : 110 - 115
  • [3] Newborn Weight Loss Tool and Readmission for Hyperbilirubinemia
    Schutzman, David L. L.
    Kuter, Nazli
    Salvador, Agnes
    Wyatt, Dorothy
    Snijder, Juan
    Peregrino, Manuel
    Basu, Rhea
    Irigoyen, Matilde
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 (10) : 1373 - 1378
  • [4] Neonatal hyperbilirubinemia: An evidence-based approach
    Pace, Emma J.
    Brown, Carina M.
    DeGeorge, Katharine C.
    JOURNAL OF FAMILY PRACTICE, 2019, 68 (01): : E4 - E11
  • [5] Newborn Metabolic Profile Associated with Hyperbilirubinemia With and Without Kernicterus
    McCarthy, Molly E.
    Oltman, Scott P.
    Baer, Rebecca J.
    Ryckman, Kelli K.
    Rogers, Elizabeth E.
    Steurer-Muller, Martina A.
    Witte, John S.
    Jelliffe-Pawlowski, Laura L.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (01): : 28 - 38
  • [6] Metalloporphyrins in the management of neonatal hyperbilirubinemia
    Stevenson, David K.
    Wong, Ronald J.
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2010, 15 (03): : 164 - 168
  • [7] Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
    Slaughter, Jonathan L.
    Kemper, Alex R.
    Newman, Thomas B.
    PEDIATRICS, 2022, 150 (03)
  • [8] Hyperbilirubinemia impact on newborn hearing: a literature review
    Teixeira, Marcela Hammes
    Silva Borges, Viviann Magalhaes
    Riesgo, Rudimar dos Santos
    Sleifer, Pricila
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (07): : 1002 - 1008
  • [9] Bilirubin Measurement and Phototherapy Use After the AAP 2022 Newborn Hyperbilirubinemia Guideline
    Sarathy, Leela
    Chou, Joseph H.
    Romano-Clarke, Giuseppina
    Darci, Katherine A.
    Lerou, Paul H.
    PEDIATRICS, 2024, 153 (04)
  • [10] Causes and management of hyperbilirubinemia in full-term newborns
    Zhu, Yan-Ping
    Wang, Jun
    Li, Ming-Xia
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 12060 - 12066